Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Esomeprazole
2. Esomeprazole Magnesium
3. Esomeprazole Potassium
4. Esomeprazole Sodium
5. Esomeprazole Strontium Anhydrous
6. Nexium
7. Strontium, Esomeprazole
1. S-omeprazole Strontium Hydrate
2. Fm0f67
3. Esomeprazole Strontium [usan]
4. 934714-36-0
5. Fm-0f67
6. C5n25h3803
7. (-)-5-methoxy-2-((s)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1h- Benzimidazole Strontium Salt Tetrahydrate
8. 1h-benzimidazole, 6-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridinyl) Methyl)sulfinyl)-, Strontium Salt, Hydrate (2:1:4)
9. Esomeprazole Strontium (usan)
10. Strontium;5-methoxy-2-[(s)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;tetrahydrate
11. Unii-c5n25h3803
12. Esomeprazole Strontium (tn)
13. Esomeprazole Strontium Hydrate
14. Chembl2146140
15. Hip1601
16. Esomeprazole Strontium Tetrahydrate
17. Hip-1601
18. Esomeprazole Strontium [vandf]
19. Esomeprazole Strontium [usp-rs]
20. Esomeprazole Strontium [who-dd]
21. Esomeprazole Strontium [orange Book]
22. Esomeprazole Strontium [usp Monograph]
23. D10120
24. Q27275225
Molecular Weight | 848.5 g/mol |
---|---|
Molecular Formula | C34H44N6O10S2Sr |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 10 |
Exact Mass | 848.16164622 g/mol |
Monoisotopic Mass | 848.16164622 g/mol |
Topological Polar Surface Area | 167 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 453 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 7 |
1 of 2 | |
---|---|
Drug Name | Esomeprazole strontium |
PubMed Health | Esomeprazole |
Drug Classes | Gastric Acid Secretion Inhibitor, Gastrointestinal Agent |
Drug Label | The active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S... |
Active Ingredient | Esomeprazole strontium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 40mg base; eq 20mg base |
Market Status | Prescription |
Company | Hanmi Pharm |
2 of 2 | |
---|---|
Drug Name | Esomeprazole strontium |
PubMed Health | Esomeprazole |
Drug Classes | Gastric Acid Secretion Inhibitor, Gastrointestinal Agent |
Drug Label | The active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S... |
Active Ingredient | Esomeprazole strontium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 40mg base; eq 20mg base |
Market Status | Prescription |
Company | Hanmi Pharm |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Esomeprazole Strontium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esomeprazole Strontium, including repackagers and relabelers. The FDA regulates Esomeprazole Strontium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esomeprazole Strontium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Esomeprazole Strontium supplier is an individual or a company that provides Esomeprazole Strontium active pharmaceutical ingredient (API) or Esomeprazole Strontium finished formulations upon request. The Esomeprazole Strontium suppliers may include Esomeprazole Strontium API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Esomeprazole Strontium Drug Master File in Korea (Esomeprazole Strontium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Esomeprazole Strontium. The MFDS reviews the Esomeprazole Strontium KDMF as part of the drug registration process and uses the information provided in the Esomeprazole Strontium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Esomeprazole Strontium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Esomeprazole Strontium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Esomeprazole Strontium suppliers with KDMF on PharmaCompass.
Esomeprazole Strontium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Esomeprazole Strontium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Esomeprazole Strontium GMP manufacturer or Esomeprazole Strontium GMP API supplier for your needs.
A Esomeprazole Strontium CoA (Certificate of Analysis) is a formal document that attests to Esomeprazole Strontium's compliance with Esomeprazole Strontium specifications and serves as a tool for batch-level quality control.
Esomeprazole Strontium CoA mostly includes findings from lab analyses of a specific batch. For each Esomeprazole Strontium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Esomeprazole Strontium may be tested according to a variety of international standards, such as European Pharmacopoeia (Esomeprazole Strontium EP), Esomeprazole Strontium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esomeprazole Strontium USP).
LOOKING FOR A SUPPLIER?